Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease - Bekker, P; Keshav, S; Wei, Z; Ertl, L; Wang, Y; Lai, N; Wright, J; Ungashe, S; Schall, T (INFLAMMATION RESEARCH, 2007)